Comerica Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $30.7M | Sell |
67,686
-339
| -0.5% | -$146K | 0.12% | 143 |
|
|
2025
Q3 | $26.6M | Buy |
68,025
+3,350
| +5% | +$1.4M | 0.1% | 188 |
|
|
2025
Q2 | $28.8M | Sell |
64,675
-746
| -1% | -$344K | 0.11% | 165 |
|
|
2025
Q1 | $31.7M | Buy |
65,421
+15,843
| +32% | +$7.38M | 0.13% | 145 |
|
|
2024
Q4 | $20M | Sell |
49,578
-4,045
| -8% | -$1.87M | 0.08% | 232 |
|
|
2024
Q3 | $24.9M | Buy |
53,623
+893
| +2% | +$429K | 0.1% | 193 |
|
|
2024
Q2 | $24.7M | Sell |
52,730
-1,650
| -3% | -$716K | 0.1% | 171 |
|
|
2024
Q1 | $22.7M | Sell |
54,380
-3,706
| -6% | -$1.57M | 0.1% | 185 |
|
|
2023
Q4 | $23.6M | Sell |
58,086
-2,070
| -3% | -$765K | 0.11% | 169 |
|
|
2023
Q3 | $20.9M | Buy |
60,156
+42,333
| +238% | +$14.8M | 0.11% | 166 |
|
|
2023
Q2 | $89 | Buy |
+17,823
| New | +$6.01M | 0.01% | 123 |
|
|
2022
Q4 | $12.1M | Buy |
38,736
+3,190
| +9% | +$972K | 0.09% | 219 |
|
|
2022
Q3 | $11M | Buy |
35,546
+1,063
| +3% | +$306K | 0.09% | 212 |
|
|
2022
Q2 | $9.99M | Sell |
34,483
-136
| -0.4% | -$36.4K | 0.08% | 243 |
|
|
2022
Q1 | $9.88M | Buy |
34,619
+294
| +0.9% | +$69.8K | 0.07% | 284 |
|
|
2021
Q4 | $7.79M | Sell |
34,325
-52,411
| -60% | -$10.2M | 0.06% | 354 |
|
|
2021
Q3 | $16.5M | Buy |
86,736
+37,937
| +78% | +$7.41M | 0.1% | 182 |
|
|
2021
Q2 | $9.52M | Sell |
48,799
-1,552
| -3% | -$325K | 0.06% | 367 |
|
|
2021
Q1 | $11M | Sell |
50,351
-685
| -1% | -$150K | 0.07% | 317 |
|
|
2020
Q4 | $12.1M | Sell |
51,036
-5,189
| -9% | -$1.19M | 0.08% | 249 |
|
|
2020
Q3 | $11.9M | Buy |
56,225
+1,309
| +2% | +$361K | 0.09% | 219 |
|
|
2020
Q2 | $16M | Buy |
54,916
+2,364
| +4% | +$641K | 0.12% | 137 |
|
|
2020
Q1 | $14.2M | Sell |
52,552
-388
| -0.7% | -$89K | 0.13% | 137 |
|
|
2019
Q4 | $12.2M | Sell |
52,940
-3,264
| -6% | -$661K | 0.09% | 205 |
|
|
2019
Q3 | $10.9M | Buy |
56,204
+560
| +1% | +$99.1K | 0.09% | 226 |
|
|
2019
Q2 | $9.86M | Buy |
55,644
+1,063
| +2% | +$186K | 0.08% | 256 |
|
|
2019
Q1 | $10.4M | Sell |
54,581
-191
| -0.3% | -$35.3K | 0.08% | 233 |
|
|
2018
Q4 | $10.2M | Sell |
54,772
-353
| -0.6% | -$61.2K | 0.09% | 235 |
|
|
2018
Q3 | $9.6M | Sell |
55,125
-14,899
| -21% | -$2.65M | 0.08% | 267 |
|
|
2018
Q2 | $12.8M | Buy |
70,024
+106
| +0.2% | +$16.4K | 0.09% | 235 |
|
|
2018
Q1 | $11.2M | Sell |
69,918
-1,296
| -2% | -$212K | 0.08% | 259 |
|
|
2017
Q4 | $11.9M | Buy |
71,214
+10,801
| +18% | +$1.6M | 0.08% | 267 |
|
|
2017
Q3 | $9.03M | Buy |
60,413
+669
| +1% | +$101K | 0.07% | 314 |
|
|
2017
Q2 | $9.92M | Sell |
59,744
-275
| -0.5% | -$33.1K | 0.07% | 275 |
|
|
2017
Q1 | $7.05M | Sell |
60,019
-898
| -1% | -$79.1K | 0.05% | 397 |
|
|
2016
Q4 | $5.07M | Buy |
60,917
+970
| +2% | +$78.9K | 0.04% | 552 |
|
|
2016
Q3 | $5.09M | Buy |
59,947
+970
| +2% | +$91.7K | 0.04% | 475 |
|
|
2016
Q2 | $6.07M | Sell |
58,977
-814
| -1% | -$70.3K | 0.05% | 399 |
|
|
2016
Q1 | $4.89M | Buy |
59,791
+864
| +1% | +$78.2K | 0.04% | 470 |
|
|
2015
Q4 | $6.52M | Sell |
58,927
-1,891
| -3% | -$228K | 0.06% | 308 |
|
|
2015
Q3 | $6.33M | Sell |
60,818
-63,672
| -51% | -$8.18M | 0.06% | 334 |
|
|
2015
Q2 | $15.4M | Buy |
124,490
+60,715
| +95% | +$7.65M | 0.07% | 290 |
|
|
2015
Q1 | $7.52M | Sell |
63,775
-61,701
| -49% | -$7.39M | 0.06% | 312 |
|
|
2014
Q4 | $14.9M | Buy |
125,476
+61,520
| +96% | +$6.93M | 0.06% | 307 |
|
|
2014
Q3 | $7.18M | Sell |
63,956
-2,779
| -4% | -$265K | 0.06% | 303 |
|
|
2014
Q2 | $6.32M | Sell |
66,735
-19,328
| -22% | -$1.36M | 0.05% | 367 |
|
|
2014
Q1 | $6.09M | Buy |
86,063
+324
| +0.4% | +$25.7K | 0.05% | 436 |
|
|
2013
Q4 | $6.37M | Sell |
85,739
-16,649
| -16% | -$1.16M | 0.05% | 396 |
|
|
2013
Q3 | $7.76M | Buy |
+102,388
| New | +$8.15M | 0.05% | 361 |
|
Other funds holding VRTX
Comerica Bank's VRTX Position: Q4 2025 in Review
Comerica Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 0.5% in Q4 2025, selling an estimated $146K and leaving 67,686 shares worth $30.7M. The position accounts for 0.12% of the portfolio, ranked #143.
Comerica Bank first reported a position in VRTX in Q3 2013 and has held it in 49 quarters since. The position peaked at $31.7M in Q1 2025. 1,669 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.
- Comerica Bank held 67,686 shares of Vertex Pharmaceuticals worth $30.7M as of Q4 2025.
- Comerica Bank sold 339 Vertex Pharmaceuticals shares in Q4 2025, an estimated $146K.
- Vertex Pharmaceuticals made up 0.12% of Comerica Bank's portfolio in Q4 2025, its #143 holding.
- Comerica Bank first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 49 quarters since.
- Comerica Bank's Vertex Pharmaceuticals position peaked at $31.7M in Q1 2025.
- 1,669 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.